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Mesorectal fasciaAim of the work: To assess utility of high resolution MRI for preoperative staging of rectal
carcinoma, mesorectal fascia involvement and circumferential resection margin.
Subjects and methods: This prospective study included 40 patients (their mean age was
54.2 years). All patients were proved pathologically to have cancer rectum located about
15 cm from the external anal verge. MRI using high resolution sequences was done to all
patients, then surgery was done, and MRI findings were correlated with pathological and
surgical outcome.
Results: Twenty-five tumors were located in the upper rectum (62.5%), 7 in the mid rectum
(17.5%), and 8 in the distal rectum (20%). MRI based T staging showed sensitivity, speci-
ficity, PPV and NPV of 95.8%, 87.5%,92% and 93.3% respectively with weighted kappa
0.84 and P_value 0.000. The sensitivity, specificity, PPV and NPV of MRI based assessment
of circumferential resection margin (CRM) were 90.0%, 96.7%, 90% and 96.7% respectively
with weighted kappa 0.86 and P_value 0.000. The accuracy, sensitivity, specificity, PPV
and NPV of nodal staging by MRI were 85%, 73.3%, 92%, 84.6% and 96.7% respectively.
Conclusion: Preoperative MRI utilizing high resolution sequences is an accurate modality
for pre-operative grading of rectal carcinoma, delineation of affection of the mesorectal fas-
cia and circumferential resection margin which are the main factors affecting the outcome
of surgery thus helping to categorize patients who can go directly for surgery from patients
who may go for neo-adjuvant therapy to avoid overtreatment.
 2016 The Egyptian Society of Radiology and Nuclear Medicine. Production and hosting by
Elsevier. This is an open access article under the CC BY-NC-ND license (http://creativecom-
mons.org/licenses/by-nc-nd/4.0/).1. Introduction
Rectal cancer being a common disease is a major cause
of death. Due to changes in the lifestyle recently, its preva-
lence has increased and is considered the third most com-
mon worldwide cancer. The most common type of allcolorectal cancers is rectal carcinoma accounting for 65%
and adenocarcinoma represents about 98% of them [1].
Local recurrence of the tumor may be related to the tumor
distance to the circumferential resection margin (CRM)
and the extramural spread of the tumor into the mesorec-
tum [1–3].
The circumferential resection margin is defined as the
distance from the edge of the tumor to the margin of the
resected specimen. One of the most vital independent pre-
dictive factors in the management of cancer rectum
patients is affection of the circumferential resection mar-
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MRI. Involvement of the circumferential resection margin
has been defined as tumor or malignant lymph node
within 1 mm of the fascia of the mesorectum [5].
Local recurrence rates of traditional rectal cancer sur-
gery are high ranging from 3% to 32% [6]. Recently dra-
matic changes occurred in treatment of cancer rectum
with the use of total mesorectal excision (TME) and the
strengthening of its value by well understanding of the
mesorectum and CRM, that led to fewer positive CRM
and fewer local recurrences. The reported recurrence rate
has been declined to below 10%, without the use of radio-
therapy [7]. Magnetic resonance imaging (MRI) utilizing
high resolution sequences can detect the rectal wall layers;
accordingly, it is crucial in preoperative staging for taking
effective therapeutic decisions. MRI using high resolution
sequences can detect the primary tumor extent, the depth
of tumor invasion, infiltration of the mesorectal fascia by
the tumor, condition of resection margin (CRM) whether
threatened or not, extramural vascular infiltration, and
lymph node (LN) status, thus helping physicians to make
effective decisions in terms of patient management [8].
In the TNM staging for rectal cancer, stage I patients (N0,
T1–2) require surgical treatment, whereas patients with
stage T3–4 tumors require preoperative chemoradiation
because it reduces the rate of local recurrence. Treatment
options also do not depend merely on differentiating stage
T2 from T3 cancer, but studies have found that patients
with extramural invasion less than 5 mm have a 5-year
survival rate of 85%, compared with 54% in patients who
have depth of more than 5 mm [9]. MRI successfully can
determine the extramural invasion depth thus aid in
appropriate treatment selection. Phased-array MRI poses
difficulty in differentiating T2 from T1 masses and in dif-
ferentiation of T1 and T2 stages from borderline T3 stage
tumors [10].
2. Subjects and methods
This prospective study was done during the period from
January 2014 to October 2015. The study was approved by
our institutional review board. All patients gave their
informed consent prior to the examination after full expla-
nation of the procedure to the patients.
2.1. Patient selection
The study population consisted of 40 patients, 14
females and 26 males (mean age, 52.3 years; with age
range 32–74 years).
2.1.1. Inclusion criteria
All patients proved pathologically to have cancer rec-
tum located about 15 cm from the external anal verge
according to their colonoscopy findings and the
histopathological results of their endoscopic biopsy.
2.1.2. Exclusion criteria
1. Long course of preoperative chemoradiotherapy.2. Patient with metastatic deposits.
Early stage rectal cancer patients were treated surgi-
cally within 25 days of the MR examination by total
mesorectal excision (TME) using anterior resection or
abdominoperineal removal or local trans-anal full-
thickness resection. Higher stages rectal cancer that was
suspected by MRI undergone surgery within 1 week of
the MR examination. The tumor size was measured in
MRI study in the three orthogonal planes and the gold
standard was resected tumor size during histopathological
examination.2.2. MR technique
Study group patients underwent high resolution MRI
using a 1.5 T unit (GE medical system, HDE 1.5 T, USA) with
phased array surface coil using non-breath-hold
sequences. Rectal cleaning enema was done 4 h before
the examination to limit misconception caused by stool.
Initially scout scanning was done followed by midline
sagittal and axial T2-weighted turbo spin-echo images.
The protocol of the scan was TE 70–90 ms, TR 3000–
4000 ms, matrix 76  384, field of view (FOV) 28–
32  28–32 cm, slice thickness 5 mm and 1 mm gap dis-
tance. High resolution T2W-FSE scans were perpendicular
to the long axis of the rectum. High-resolution T2W proto-
col (TE 108 ms, TR 4200–5000 ms, slice 3 mm, 210–300 s
acquisition time, FOV 180–240 mm) in sagittal, coronal
and axial series all perpendicular to the long axis of the
rectal tumor was generated. Other routine sequences were
also used such as axial T1WI, axial FSE T2WI with fat sup-
pression (FS), sagittal T1WI, sagittal T2, and sagittal FSE T2
FS. No contrast was given and no lumen distension tech-
nique was used. The cases were reviewed by two radiolo-
gists separately.2.3. Image analysis
Staging by high resolution T2 MRI of rectal cancer
mainly depends on variances in T2 signal intensity
between the rectal wall layers and the mass. On T2WI, 3
different layers can be visualized: hyperintense inner layer
representing the mucosa and submucosa, and cannot be
differentiated, intermediate hypointense layer represent-
ing the muscularis propria and hyperintense outer layer
of perirectal fat. The mesorectal fascia appears as low-
intensity thin layer enclosing the mesorectum and is obvi-
ously visible on the posterior and lateral views [11].
TNM classification was applied for T-staging of the
study group [12] and was evaluated according to the
described criteria. Owing to difficult differentiation of T1
and T2 lesions, joining of both stages was done in one
group of intramural lesions 6T2 stage showing tumor sig-
nal intensity limited to the muscular layer with preserved
interface between the perirectal fat and the muscularis
propria. T staging and MR staging are summarized in
(Table 1). The circumferential resection was evaluated
and considered positive when tumor or malignant lymph
node is within 1 mm of the fascia of the mesorectum [5].
Table 1
Histological T-staging of rectal carcinoma with corresponding MR staging,
adapted from the American Joint Committee on Cancer staging system [35]
and Rao et al., 2007 [30].
Histological T-staging MR T-appearance
T1: Submucosal invasion MR-T1: Signal intensity of the
mass limited to the submucosal
layer
T2: Muscularis propria invasion MR-T2: Signal intensity of the
tumor spreads into the muscle
layer, with loss of the interface
between the circular muscle
layer and submucosa
T3: mass grows through the
muscularis propria then into
the mesorectum
MR-T3: Signal intensity of the
tumor spreads through the
muscle layer into the perirectal
fat, with obliteration of the
interface between perirectal fat
and muscle layer
T3-A mass extends < 5 mm
outside the muscularis
propria
T3-B mass extends 5–10 mm
outside the muscularis
propria
T3-C mass extends > 10 mm
outside the muscularis
propria
T4: MR-T4: Signal intensity of the
tumor spreads into adjacent
viscus or structure
T4-A visceral peritoneum
penetration
T4-B mass invades or adherent
to other structure organs
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lymph nodes were evaluated based on their number and
their size. Lymph nodes with 5 mm short axis diameter
or greater were considered metastatic, while nodes < 5 mm
were considered to be uninvolved. Also margin irregular-
ity, speculation, and eccentric necrosis were considered
as signs of nodal involvement.
3. Results
40 patients include 14 females and 26 males (mean age,
52.3 years; with age range 32–74 years). The cases were
reviewed by two radiologists separately. Inter-observer
agreement on the MRI findings between the 2 radiologists
was 95%; in particular, the two examiners were coincident
in 38 of 40 patients. In those 2 cases, the disagreement was
in nodal affection and was agreed after conjoint re-
examination of the study.
The rectal masses were well visualized in all patients. In
the upper rectum 25 tumors were located (10–15 cm from
the anal verge, 62.5%), in the mid rectum 7 tumors (5–
10 cm from the anal verge, 17.5%), and in the distal rectum
8 tumors (less than 5 cm from the anal verge, 20%). The
size of the tumor ranged between 2.2 and 9 cm, with mean
tumor size of 5.1 cm. The resected tumor size ranged from
0.8 cm  2.2 cm to 6 cm  7.2 cm (mean 3.6 cm  4.5 cm).
3.1. T staging
Histopathological staging revealed that intramural
lesions (T1 + T2 stage) were found in 16 patients (40%, Figs
2 and 3), T3 in 20 patients (50%, Figs. 1 and 5) and T4 in 4
patients (10%, Figs. 4 and 6) (Table 2).Tumor invasion of the rectal wall was correctly assessed
by MRI in 14/16 intramural lesions (87.5%), in 19/20 of (T3)
lesions (95%) and in 3/4 of (T4) lesions (75%). Two (T2)
tumors were over-staged as T3 owing to the presence of
desmoplastic reaction or 1 mm reactive tissue that could
not be discriminated from actual mesorectal tumor inva-
sion (Fig. 3). Single patient out of the 20 patients with T3
tumors was under-staged due to a slight mesorectal inva-
sion that could not be detected (Fig. 1). Another patient
out of the 4 patients staged as T4 was under-staged as
T3, owing to non-detectable seminal vesicle invasion
(Table 2). The calculated sensitivity, specificity, PPV and
NPV of MRI based staging were 95.8%, 87.5%, 92% and
93.3% respectively with weighted kappa 0.84 and P_value
0.000 (Table 3).
3.2. Status of the mesorectal fascia
The mesorectal fascia was well visualized in all patients
on MRI, appearing as low-signal-intensity a thin structure
surrounds the perirectal fat and enveloping the mesorec-
tum [5]. It was affected in 10 patients evidenced by
histopathological study using 2 mm between a tumor
and the mesorectal fascia as a cutoff distance. The accuracy
of MRI in predicting involvement of the mesorectal fascia
was 88.9%. The sensitivity, specificity, positive predictive
value, and negative predictive value were 90% (9/10), 90%
(27/30), 72.3% (8/11) and 93.1% (27/29), respectively. One
false positive case was anterior rectal tumor. One false-
negative case was found due to inability to identify nodal
metastases within 2 mm, which is still a diagnostic prob-
lem on MRI.
3.3. Circumferential resection margin (CRM)
Based on involvement of mesorectal fascia by MRI, CRM
was evaluated independently by the two radiologists for
predicting its involvement. MRI properly predicted nega-
tive CRM in 29 patients out of the 30 patients with non
involved mesorectal fascia. One false-positive observed in
one tumor located anteriorly. One positive CRM was eval-
uated in 9 out of the 10 cases of pathologically proven
involved mesorectal fascia and CRM. Single false-negative
tumor was found in low located rectal cancer owing to
the gradual narrowing of the mesorectal tissue.
The sensitivity, specificity, PPV and NPV of CRM assess-
ment by MRI were 90.0%, 96.7%, 90% and 96.7% respec-
tively with weighted kappa 0.86 and P_value 0.000
(Table 3).
3.4. N staging
Fifteen patients showed metastatic nodes at histo-
pathological study (1pT1, 2pT2, 11pT3, 1pT4) out of the
40 patients with cancer rectum. MRI predicts metastatic
nodes correctly in 13 of the 15 patients visualized in MRI,
while two cases in the other 25 cases were categorized
by MRI as reactive LNs owing to regular borders and small
size (<5 mm) that proved by histopathology to be meta-
static nodes. The 2 false-positive nodes were diagnosed
as N1 by MRI due to reactive lymph nodes greater than
Fig. 1. Male, 48 years old with histopathologically proven T3 stage rectal carcinoma MRI. (a) High resolution T1WI, (b) high resolution T2WI, (c) high
resolution T2WI with FS (fat saturation). Rectal mass (white arrow) with reticulo-nodular stranding of the mesorectal fat at the left lateral aspect. Enlarged
lymph nodes on both sides of the mesorectal fat (black arrow) proved to N1.
Fig. 2. Male, 42 years old with histopathologically proven T1 stage rectal carcinoma. Rectal MRI, (a) high resolution T2WI, (b) sagittal T2WI. Case of upper
third rectal carcinoma showing subtle minimal mucosal thickening extending to muscular layer (arrow).
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specificity, PPV and NPV of nodal staging by MRI were
85%, 73.3%, 92%, 84.6% and 96.7% respectively (Table 4).
All cases show no extramural vascular invasion.4. Discussion
MRI using high-resolution sequences shows important
role in the multimodality imaging of rectal cancer patients
Fig. 3. Male, 46 years old with histopathologically proven T2 stage rectal carcinoma. Rectal MRI, (a) high resolution T2WI, (b) high resolution T1WI. Case of
middle third rectal carcinoma showing muscular wall involvement and reticulo-nodular stranding of the mesorectal fat at the anterior aspect (arrow)
sparing the seminal vesicles.
Fig. 4. 50-year-old male with pathologically proven T4 stage rectal carcinoma. Rectal MRI, (a and c) high resolution T2WI, (b) axial T1WI, (d) coronal T2WI.
Rectal carcinoma showing disruption of the outer layer, mesorectal fascia involvement at its right postero-lateral aspect (arrow), positive CRM with
multiple enlarged pelvic and mesorectal LNs showing irregular outline and speculations (N2) (arrow head).
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staging is crucial for making effective therapeutic deci-
sions. MRI combining large fields of view and high spatial
resolution, represents the top advanced modality for stag-
ing being able to provide information about the tumor
invasion depth, relationship of the mesorectal fascia to
the tumor, affection of CRM, extramural vascular invasion
and lymph node grading [7,8,10], therefore enabling physi-
cians to take effective decisions in patient management
and helping to improve quality of life and overall survival
in patients with rectal carcinoma. Cancer rectum has
higher recurrence rate than other colonic carcinoma
because of extensive pelvic lymphatic drainage. The recur-rence rate can be reduced by TME by removal of the rec-
tum containing the tumor and its draining lymph nodes
as one distinct package [13]. The local recurrence rate at
a 2-year follow-up can be reduced from 8.2% to 2.4% by
the combination of TME and preoperative radiotherapy
compared to TME alone, and that was mostly valuable for
T3 or T4 or nodal positive tumors [14–16]. Therefore pre-
operative imaging is vital to select patients for suitable
management [17–21]. High resolution T2 acquired in two
planes at least is now considered the essential part MRI
evaluation [22,23]; several authors stated that the axial
plane perpendicular to the rectal tumor is important, while
the use of gadolinium enhanced T1WI sequences is unnec-
Fig. 5. Female, 46 year old with histopathologically proven T3 stage rectal carcinoma. Rectal MRI, (a and b) high resolution T2WI, (c) sagittal T2WI, (d)
endoscopy of the lesion. Case of upper third rectal carcinoma opposite to 12–7 o’clock (white arrow) with polypoidal left lateral extension into the
mesorectal fascia (black arrow) and positive CRM. Multiple enlarged mesorectal LNs are noted showing irregular outline (N1) (arrow head).
Fig. 6. Female, 44 year old with histopathologically proven T4 stage rectal carcinoma. Rectal MRI, (a) high resolution axial T2WI, (b) sagittal T2WI, (c) axial
T2 at lower level. Lower third rectal carcinoma extending to the mesorectal fascia and positive CRM (black arrow). Multiple enlarged pelvic and mesorectal
LNs are noted showing irregular outline (N2) (white arrow).
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Table 2
MRT staging in contrast to surgical and histological based T staging in 40 patients.
Staging by MRI Histological staging Total
T1 + T2 T3 T4
T1 + T2 (14/16) 14 1 0 15
T3 (19/20) 2 19 1 22
T4 (3/4) 0 0 3 3
Total (%) 16 (40%) 20 (50%) 4 (10%) 40
Table 3
Agreement between histological diagnosis and MRI-T staging and CRM affection.
MRI analysis Weighted kappa P_value Sensitivity Specificity PPV NPV
T staging 0.84 0.000 95.8 87.5 92 93.3
CRM 0.86 0.000 90.0 96.7 90 96.7
Table 4
Agreement between histological diagnosis and MRI in nodal staging.
MRI analysis Accuracy Sensitivity Specificity PPV NPV
N staging 85% 73.3% 92% 84.6% 92%
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given. Several similar series stated that the overall match-
ing between MRI and histopathological examination for T
staging ranged from 66% to 94% [5,25–27]. Differentiation
between T2 and T3 tumors is challenging in MRI. In our
study MRI T-staging shows agreement with histological
T-staging in 36 out of 40 patients with mismatch in 4
patients, 3 of them were due to under or over staging of
T2 and T3 category in accordance with Iannicelli et al. [7]
and Ghieda et al. [28], discrepancy occurred because
desmoplastic reaction or reactive tissue cannot be distin-
guished from true mesorectal tumor invasion (in 2 cases)
and minimal mesorectal invasion is not depicted (in 1
patient). The sensitivity, specificity, PPV and NPV of T stag-
ing based on MRI were 95.8%, 87.5%, 92% and 93.3% respec-
tively with weighted kappa 0.84 and P_value 0.000, in
accordance with Ghieda et al. [28] and Iannicelli et al. [7]
that stated that differentiation between T3 borderline
lesions and intramural tumors still has a diagnostic prob-
lem because usually it is difficult to discriminate desmo-
plastic reaction or peritumoral inflammatory tissue that
may or may not contain tumor cells from a true mesorectal
tumor invasion. There is controversy in the set of the best
MR technique to use for staging rectal cancer and for
assessing CRM involvement; several authors prefer to per-
form the MRI without distension of the rectal lumen,
assuming that it may alter the distance between the
mesorectal fascia and the tumor and may compromise
evaluation of the CRM [29]. Others advocate distension of
the rectal lumen with water, super paramagnetic iron
oxide solutions, warm US gel or methylcellulose to
improve detection of the tumor [30–32]. In the current
study, the sensitivity, specificity, PPV and NPV of CRM
assessment by MRI were 90.0%, 96.7%, 90% and 96.7%
respectively with weighted kappa 0.86 and P_value
0.000. One false-positive occurred in anterior located
tumor which was thin and 1 false-negative tumor in lowlocated rectal cancer owing to the gradual narrowing of
the mesorectal tissue, in agreement with Rao et al. [8]
and Iannicelli et al. [7] studies, and these two studies were
done with lumen air distension and also in agreement with
Algebally et al. study [5] that was done without. Slater
et al. [29] study was based on comparing the measurement
of the CRM at the same level in two groups of patients with
and without distension of the rectum and concluded that
distension of the rectal lumen decreases the distance
between the mesorectal fascia and the wall of the rectum
and there is no significant difference between both.
Any specimen showing tumor 6 1 mm from the
mesorectal fascia was considered having positive margin
by the pathologists [33,34], although the criteria of
62 mm [8] have been suggested to be more reliable and
that was the cut-off value in the current study. Regarding
nodal assessment, the accuracy, sensitivity, specificity,
PPV and NPV of nodal staging by MRI were 85%, 73.3%,
92%, 84.6% and 96.7% respectively, and these results are
in accordance with other studies done using distension of
the rectal lumen [7,8], or without rectal distension [29].
To our limited knowledge, no imaging modality can evalu-
ate the lymph node status with a relevant degree of accu-
racy. The standardized and optimal criteria to define
metastatic involvement of local lymph-node have not yet
been established as demonstrated in meta-analysis of 21
articles [12,3].5. Conclusion
Preoperative MRI utilizing high resolution sequences is
an accurate modality for pre-operative grading of rectal
carcinoma, delineation of affection of the mesorectal fascia
and circumferential resection margin which are the main
factors affecting the outcome of surgery thus helping to
categorize patients who can go directly for surgery from
patients who may go for neo-adjuvant therapy to avoid
overtreatment.References
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